Suppr超能文献

卢旺达性风险高的女性参与试点随机对照试验中阴道益生菌的黏附性和可接受性:混合方法研究。

Vaginal probiotic adherence and acceptability in Rwandan women with high sexual risk participating in a pilot randomised controlled trial: a mixed-methods approach.

机构信息

Department of Clinical Infection, Microbiology and Immunology, Institute of Infection and Global Health, University of Liverpool, Liverpool, Merseyside, UK.

Rinda Ubuzima, Kigali, Rwanda.

出版信息

BMJ Open. 2020 May 19;10(5):e031819. doi: 10.1136/bmjopen-2019-031819.

Abstract

OBJECTIVES

To evaluate adherence and acceptability of intermittent vaginal probiotic or antibiotic use to prevent bacterial vaginosis (BV) recurrence.

DESIGN

Repeated adherence and acceptability assessments using mixed methods within a pilot randomised controlled trial.

SETTING

Research clinic in Kigali, Rwanda.

PARTICIPANTS

Rwandan women with high sexual risk.

INTERVENTIONS

Women diagnosed with BV and/or trichomoniasis were randomised to four groups (n=17 each) after completing metronidazole treatment: behavioural counselling only, or behavioural counselling plus 2-month intermittent use of oral metronidazole, Ecologic Femi+ (EF+) vaginal capsule or Gynophilus LP (GynLP) vaginal tablet.

OUTCOME MEASURES

Adherence and acceptability were assessed by structured face-to-face interviews, semi-structured focus group discussions and in-depth interviews, daily diaries and counting of used/unused study products in randomised women (n=68). Vaginal infection knowledge was assessed by structured face-to-face interviews in randomised women and women attending recruitment sessions (n=131).

RESULTS

Most women (93%) were sex workers, 99.2% were unfamiliar with BV and none had ever used probiotics. All probiotic users (n=32) reported that insertion became easier over time. Triangulated adherence data showed that 17/17 EF+ users and 13/16 GynLP users used ≥80% of required doses (Fisher's exact p=0.103). Younger age (p=0.076), asking many questions at enrolment (p=0.116), having menses (p=0.104) and reporting urogenital symptoms (p=0.103) were non-significantly associated with lower perfect adherence. Women believed that the probiotics reduced BV recurrence, but reported that partners were sometimes unsupportive of study participation. Self-reported vaginal washing practices decreased during follow-up, but sexual risk behaviours did not. Most women (12/15) with an uncircumcised steady partner discussed penile hygiene with him, but many women found this difficult, especially with male clients.

CONCLUSIONS

High-risk women require education about vaginal infections. Vaginal probiotic acceptability and adherence were high in this cohort. Our results can be used to inform future product development and to fine-tune counselling messages in prevention programmes.

TRIAL REGISTRATION NUMBER

NCT02459665.

摘要

目的

评估间歇性阴道益生菌或抗生素预防细菌性阴道病(BV)复发的依从性和可接受性。

设计

在一项试点随机对照试验中,使用混合方法进行反复的依从性和可接受性评估。

地点

卢旺达基加利的研究诊所。

参与者

性风险较高的卢旺达妇女。

干预措施

在完成甲硝唑治疗后,将诊断为 BV 和/或滴虫病的妇女随机分为四组(每组 17 人):仅行为咨询,或行为咨询加 2 个月间歇性口服甲硝唑、Ecologic Femi+(EF+)阴道胶囊或 Gynophilus LP(GynLP)阴道片。

结果

在随机分组的妇女(n=68)中,通过结构化面对面访谈、半结构化焦点小组讨论和深入访谈、每日日记和计算使用/未使用的研究产品来评估依从性和可接受性。在随机分组的妇女和参加招募会议的妇女(n=131)中,通过结构化面对面访谈评估阴道感染知识。

大多数妇女(93%)为性工作者,99.2%对 BV 不熟悉,且无人曾使用过益生菌。所有益生菌使用者(n=32)均报告说,随着时间的推移,插入变得更容易。三角化的依从性数据显示,17/17 名 EF+使用者和 13/16 名 GynLP 使用者使用了≥80%所需剂量(Fisher 确切检验 p=0.103)。年轻(p=0.076)、入组时提出许多问题(p=0.116)、经期(p=0.104)和报告泌尿生殖症状(p=0.103)与完全依从性较低无显著相关性。妇女认为益生菌减少了 BV 的复发,但报告说伴侣有时不支持参与研究。在随访期间,自我报告的阴道冲洗行为减少,但性风险行为没有减少。大多数(12/15)有未割包皮的稳定伴侣的妇女与他讨论了阴茎卫生问题,但许多妇女发现这很困难,尤其是对男性客户。

结论

高危妇女需要接受阴道感染方面的教育。在本队列中,阴道益生菌的可接受性和依从性较高。我们的研究结果可用于指导未来产品的开发,并微调预防计划中的咨询信息。

试验注册号

NCT02459665。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验